
SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), relating to the proposed merger with Merck KGaA, Darmstadt, Germany. Under the terms of the agreement, SpringWorks shareholders will receive $47.00 in cash per share of SpringWorks stock held.
SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), relating to the proposed merger with Merck KGaA, Darmstadt, Germany. Under the terms of the agreement, SpringWorks shareholders will receive $47.00 in cash per share of SpringWorks stock held.